Value Evaluation of Quantitative Aspergillus fumigatus-Specific IgG Antibody Test in the Diagnosis of Non-neutropenic Invasive Pulmonary Aspergillosis

References

• Larkin PMK, Multani A, Beaird OE, et al. A collaborative tale of diagnosing and treating chronic pulmonary aspergillosis, from the perspectives of clinical microbiologists, surgical pathologists, and infectious disease clinicians. J Fungi. 2020;6(3). doi:10.3390/jof6030106
   Web of Science ®Google Scholar
• Samson RA, Visagie CM, Houbraken J, et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud Mycol. 2014;78:141–173. doi:10.1016/j.simyco.2014.07.004
   PubMed Web of Science ®Google Scholar
• Hospenthal DR, Kwon-Chung KJ, Bennett JE. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol. 1998;36(3):165–168.
   PubMed Web of Science ®Google Scholar
• Richardson MD, Page ID. Aspergillus serology: have we arrived yet? Med Mycol. 2017;55(1):48–55. doi:10.1093/mmy/myw116
   PubMed Web of Science ®Google Scholar
• Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Investig. 2002;109(6):699–705. doi:10.1172/jci15277
   PubMed Web of Science ®Google Scholar
• Jenks JD, Salzer HJF, Hoenigl M. Improving the rates of Aspergillus detection: an update on current diagnostic strategies. Exp Rev Anti-Infective Ther. 2019;17(1):39–50. doi:10.1080/14787210.2018.1558054
   PubMed Web of Science ®Google Scholar
• Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clinl Infect Dis. 2010;50(12):1559–1567. doi:10.1086/652768
   PubMed Web of Science ®Google Scholar
• Bongomin F, Asio LG, Baluku JB, et al. Chronic pulmonary aspergillosis: notes for a clinician in a resource-limited setting where there is no mycologist. J Fungi. 2020;6(2). doi:10.3390/jof6020075
   Web of Science ®Google Scholar
• Maertens JA, Klont R, Masson C, et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clinl Infect Dis. 2007;44(10):1329–1336. doi:10.1086/514349
   PubMed Web of Science ®Google Scholar
• Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clinl Infect Dis. 2011;52(6):750–770. doi:10.1093/cid/ciq206
   PubMed Web of Science ®Google Scholar
• Takazono T, Izumikawa K. Recent advances in diagnosing chronic pulmonary aspergillosis. Front Microbiol. 2018;9:1810. doi:10.3389/fmicb.2018.01810
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J clin oncol. 2002;20(7):1898–1906. doi:10.1200/jco.2002.07.004
   PubMed Web of Science ®Google Scholar
• Yu Q, He J, Xing B, et al. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients. BMC Pulm Med. 2020;20(1):89. doi:10.1186/s12890-020-1125-y
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the Mycoses Study Group Education and Research Consortium. Clinl Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz1008
   PubMed Web of Science ®Google Scholar
• Liu L, Gu Y, Wang Y, Shen K, Su X. The clinical characteristics of patients with nonneutropenic invasive pulmonary aspergillosis. Front Med. 2021;8:631461. doi:10.3389/fmed.2021.631461
   Web of Science ®Google Scholar
• Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Europ Resp J. 2016;47(1):45–68. doi:10.1183/13993003.00583-2015
   PubMed Web of Science ®Google Scholar
• Patterson TF, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clinl Infect Dis. 2016;63(4):e1–e60. doi:10.1093/cid/ciw326
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergillosis in the intensive care unit. Clinl Infect Dis. 2007;45(2):205–216. doi:10.1086/518852
   PubMed Web of Science ®Google Scholar
• Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, et al. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intens Care Med. 2007;33(10):1694–1703. doi:10.1007/s00134-007-0791-z
   PubMed Web of Science ®Google Scholar
• Page ID, Richardson MD, Denning DW. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA). J Infect. 2016;72(2):240–249. doi:10.1016/j.jinf.2015.11.003
   PubMed Web of Science ®Google Scholar
• Page ID, Richardson M, Denning DW. Antibody testing in aspergillosis--quo vadis? Med Mycol. 2015;53(5):417–439. doi:10.1093/mmy/myv020
   PubMed Web of Science ®Google Scholar
• Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clinl Infect Dis. 2006;43(5):577–584. doi:10.1086/505870
   PubMed Web of Science ®Google Scholar
• Wu Z, Wang L, Tan L, et al. Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients. Diagnos Microbiol Infect Dis. 2021;99(4):115274. doi:10.1016/j.diagmicrobio.2020.115274
   PubMed Web of Science ®Google Scholar
• Lu Y, Liu L, Li H, et al. The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis. Clin Microbiol Infect. 2023;29(6):797.e1–797.e7. doi:10.1016/j.cmi.2023.02.002
   PubMed Web of Science ®Google Scholar
• Dobias R, Jaworska P, Tomaskova H, et al. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients. Mycoses. 2018;61(8):576–586. doi:10.1111/myc.12765
   PubMed Web of Science ®Google Scholar
• Shankar J, Thakur R, Clemons KV, et al. Interplay of cytokines and chemokines in Aspergillosis. J Fungi. 2024;10(4):251. doi:10.3390/jof10040251
   Web of Science ®Google Scholar
• Jenks JD, Mehta SR, Taplitz R, et al. Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies. J Infect. 2019;78(3):249–259. doi:10.1016/j.jinf.2018.10.014
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Eigl S, Heldt S, et al. Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis. Mycoses. 2018;61(1):40–43. doi:10.1111/myc.12704
   PubMed Web of Science ®Google Scholar
• Davies G, Singh O, Prattes J, et al. Aspergillus fumigatus and its allergenic ribotoxin Asp f I: old enemies but new opportunities for urine-based detection of invasive pulmonary aspergillosis using lateral-flow technology. J Fungi. 2020;7(1). doi:10.3390/jof7010019
   Web of Science ®Google Scholar